Mucocutaneous diseases and murine models with death of keratinocytes induced by lichenoid tissue reaction/interface dermatitis

Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology
Naoko Okiyama

Abstract

A set of histopathological elements with death of epidermal basal cell layer keratinocytes along with inflammatory cell infiltration distinguishes lichenoid tissue reaction (LTR)/interface dermatitis (IFD) from other inflammatory mucocutaneous diseases. The LTR/IFD can be seen in skin disorders like as lichen planus, acute graft-versus-host disease, lupus erythematosus, dermatomyositis, and toxic epidermal necrolysis/Stevesn-Johnson syndrome. Clinical and basic researches suggested that cytotoxic CD8 T cells producing interferon-γ and FasL are final effector cells to cause apoptosis of keratinocyte. Some murine models of LTR/IFD have been established, for example, LTR/IFD reactions of keratinocyte-specific ovalbumin (OVA)-transgenic mice after OVA-specific T-cell-receptor(+)CD8 T cells. By analysis of the murine model, a new class of immunosuppressant, a JAK inhibitor, has been suggested as a new candidate for treatment of LTR/IFD.

References

Jul 1, 1988·Transplant International : Official Journal of the European Society for Organ Transplantation·D MaraninchiG Novakovitch
Jun 1, 1981·Springer Seminars in Immunopathology·R D Sontheimer, J N Gilliam
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·R W GrovesT S Kupper
Aug 1, 1997·Archives of Dermatological Research·M ShimizuM Kawashima
Aug 23, 2002·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·P B SugermanM Bigby
Apr 23, 2003·The American Journal of Pathology·Riichiro AbeHiroshi Shimizu
Jun 18, 2003·European Journal of Immunology·Hiroaki AzukizawaSatoshi Itami
Aug 26, 2004·The British Journal of Dermatology·L Prpić MassariD Rukavina
Sep 29, 2004·Archives of Dermatological Research·Marija KastelanDanijel Rukavina
Nov 13, 2004·The Journal of Allergy and Clinical Immunology·Amal NassifJean-Claude Roujeau
Feb 17, 2005·The Journal of Pathology·Amerigo SantoroFabio Facchetti
May 17, 2005·Autoimmunity Reviews·Tetsuo Shiohara, Yoshiko Mizukawa
May 24, 2005·European Journal of Immunology·Hiroaki AzukizawaSatoshi Itami
Jun 15, 2005·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·Giovanni LodiKobkan Thongprasom
May 24, 2006·Clinical and Experimental Dermatology·J WenzelT Tüting
Aug 2, 2006·The Journal of Experimental Medicine·Ronjon ChakravertyMegan Sykes
Oct 10, 2006·Journal of Cutaneous Pathology·Joerg WenzelThomas Tüting
Jun 26, 2007·Molecular Cell·Tom Vanden BerghePeter Vandenabeele
Sep 8, 2007·Dermatology : International Journal for Clinical and Investigative Dermatology·Marina SchelerJoerg Wenzel
Sep 15, 2007·The British Journal of Dermatology·T M JärvinenU Saarialho-Kere
Mar 4, 2008·Methods : a Companion to Methods in Enzymology·Dmitri V KryskoPeter Vandenabeele
Mar 12, 2008·Journal of Cutaneous Pathology·M AmmarH Louzir
Feb 6, 2010·The Journal of Allergy and Clinical Immunology·Esther MorelTeresa Bellón
Aug 9, 2011·The Journal of Clinical Investigation·Hayato TakahashiMasayuki Amagai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis